CONSULTING AGREEMENTConsulting Agreement • June 7th, 2016 • Pivot Pharmaceuticals Inc. • Pharmaceutical preparations • British Columbia
PIVOT PHARMACEUTICALS INC., a British Columbia corporation having an address at 1275 West 6th Avenue, Vancouver, British Columbia V6H 1A6
DIRECTOR'S AGREEMENTDirector's Agreement • December 15th, 2015 • Pivot Pharmaceuticals Inc. • Pharmaceutical preparations • British Columbia
PIVOT PHARMACEUTICALS INC., a corporation of the province of British Columbia with offices at 1275 West 6th Avenue, Vancouver, British Columbia, Canada V6H 1A6.
DIRECTOR’S AGREEMENTOption Agreement • August 7th, 2009 • Neurokine Pharmaceuticals Inc.
NEUROKINE PHARMACEUTICALS INC., a corporation incorporated under the laws of British Columbia having its principal business office at 1275 West 6th Avenue, Vancouver, British Columbia, V6H 1A6
SUBSCRIPTION AGREEMENT – DEBT SETTLEMENTSubscription Agreement • December 16th, 2013 • Neurokine Pharmaceuticals Inc. • Pharmaceutical preparations • British Columbia
Ahmad Doroudian (the “Subscriber”) wishes to subscribe for 35,000,000 shares of common stock in the capital stock of the Company (the “Shares”), at a deemed price of $0.001 per Share, for an aggregate cost of $35,000;
SHAREHOLDER’S AGREEMENTShareholder’s Agreement • August 7th, 2009 • Neurokine Pharmaceuticals Inc.
Neurokine Pharmaceuticals Inc., a company incorporated under the laws of British Columbia having a registered office at Suite 1820 Cathedral Place 925 West Georgia Street Vancouver, BC V6C 3L2
THIS EMPLOYMENT AGREEMENT is as of the 1st day of February, 2016 BETWEEN:Employment Agreement • June 7th, 2016 • Pivot Pharmaceuticals Inc. • Pharmaceutical preparations • British Columbia
PIVOT PHARMACEUTICALS INC., a corporation incorporated pursuant to the laws of the Province of British Columbia and having an address of Suite 300, 1275 West 6th Avenue, Vancouver, B.C., Canada, V6C 1V5
Private Placement Subscription Agreement for Non U.S. Residents Name of Purchaser Hassan Salari (the “Purchaser”)Neurokine Pharmaceuticals Inc. • August 12th, 2010 • Pharmaceutical preparations
The Purchaser subscribes for and agrees to purchase from Neurokine Pharmaceutical Inc., a British Columbia (the "Company"), units with each unit (the “Unit”) consisting of one share of our common stock and one warrant, to purchase a quarter (¼) of a share of common stock of the Company at an exercise price of US$0.05 per share and in accordance other terms as set out in Schedule “D” hereto , to be recorded in the name of the Purchaser at the address set out above, all on the terms and subject to the conditions set forth in Schedule “A” attached hereto.
PIVOT – SOLMIC COLLABORATION AND LICENSE AGREEMENTSolmic Collaboration and License Agreement • December 15th, 2017 • Pivot Pharmaceuticals Inc. • Pharmaceutical preparations
This COLLABORATION AND LICENSE AGREEMENT is made this 23rd day of September 2017 (hereinafter the “Effective Date”), by and between PIVOT PHARMACEUTICALS INC., a corporation organized under the laws of British Columbia with an address c/o 1275 West 6th Street, Suite 300, Vancouver, BC V6C 1A6 (hereinafter “PIVOT”) and SolMic GmbH, a corporation organized under the laws of Germany with an address Merowingerplatz 1a, 40225 Dusseldorf, Germany, (hereinafter “SOLMIC”). PIVOT and SOLMIC herein may be referred to individually as “Party” or together as “Parties.”
DIRECTOR’S AGREEMENTEscrow Agreement • March 26th, 2015 • Neurokine Pharmaceuticals Inc. • Pharmaceutical preparations • British Columbia
NEUROKINE PHARMACEUTICALS INC., a corporation of the province of British Columbia with offices at 1275 West 6th Avenue, Vancouver, British Columbia, Canada V6H 1A6.
THIS EMPLOYMENT AGREEMENT dated for reference March 1, 2018 BETWEEN:Employment Agreement • March 12th, 2018 • Pivot Pharmaceuticals Inc. • Pharmaceutical preparations • California
PIVOT PHARMACEUTICALS INC., a corporation amalgamated under the Canada Business Corporations Act and having its head office at #300-1275 West 6th Avenue, Vancouver, British Columbia Canada, V6H 1A6 (the “Company”)
DEBT FORGIVENESS AGREEMENTDebt Forgiveness Agreement • September 15th, 2017 • Pivot Pharmaceuticals Inc. • Pharmaceutical preparations • British Columbia
This Debt Forgiveness Agreement (“Agreement”), entered into effective July 31, 2017, by and between Pivot Pharmaceuticals Inc. (the “Company”) and Moira Ong (“Lender”), in reference to the following:
UNANIMOUS SHAREHOLDERS’ AGREEMENTAgreement • December 19th, 2018 • Pivot Pharmaceuticals Inc. • Pharmaceutical preparations • Quebec
NOW THEREFORE, this Agreement witnesses that for and in consideration of the mutual promises, covenants and agreements as hereinafter contained, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged by each of the Parties, the Parties agree as follows:
DEBT FORGIVENESS AGREEMENTDebt Forgiveness Agreement • September 15th, 2017 • Pivot Pharmaceuticals Inc. • Pharmaceutical preparations • British Columbia
This Debt Forgiveness Agreement (“Agreement”), entered into effective July 31, 2017, by and between Pivot Pharmaceuticals Inc. (the “Company”) and Soho Capital Inc. (“Lender”), in reference to the following:
DIRECTOR’S AGREEMENTAgreement • March 26th, 2015 • Neurokine Pharmaceuticals Inc. • Pharmaceutical preparations • British Columbia
NEUROKINE PHARMACEUTICALS INC., a corporation of the province of British Columbia with offices at 1275 West 6th Avenue, Vancouver, British Columbia, Canada V6H 1A6.
AGREEMENT AND PLAN OF MERGER AND ACQUISITION AGREEMENT AMONG PIVOT PHARMACEUTUCALS, INC. AND PIVOT PHARMA U.S. INC. AND INDUS PHARMACEUTICALS, INC., AND SINDU RESEARCH LABORATORIES PVT. LTD.Agreement and Plan of Merger and Acquisition Agreement • November 23rd, 2015 • Pivot Pharmaceuticals Inc. • Pharmaceutical preparations • Delaware
This Merger Agreement (this ''Agreement'') is entered into as of November 4, 2015, by and among Pivot Pharmaceuticals, Inc. a British Columbia Corporation with its principal place of business located at 1275 West 6th Avenue, Vancouver, B.C., Canada, V6H 1A6 ("Buyer"), Pivot Pharma U.S. Inc., a Delaware corporation and a wholly owned Subsidiary of Buyer ("Merger Subsidiary"), IndUS Pharmaceuticals, Inc., a Delaware corporation ("Seller"), Sindu Research Laboratories Pvt Ltd., a corporation formed under the laws of India ("Sindu") and the Sindu Stockholders (as defined below). Buyer, Merger Subsidiary, Seller and Sindu are referred to collectively herein as the "Parties".
MANAGEMENT CONSULTING AGREEMENTManagement Consulting Agreement • August 7th, 2009 • Neurokine Pharmaceuticals Inc. • British Columbia
MASTER SERVICE AGREEMENTMaster Service Agreement • December 3rd, 2009 • Neurokine Pharmaceuticals Inc. • Pharmaceutical preparations • British Columbia
This Master Service Agreement (the “Agreement”) is made as of October 2, 2007 (the “Effective Date”) between Northern Lipids Inc., a contract research organization, with its principal place of business located at BC Research Institute, 3650 Wesbrook Mall, Vancouver B.C., Canada V6S 2L2 (“NLI”), and Neurokine Pharmaceuticals Inc. with its principal place of business located at 1275 West 6th Avenue, Vancouver, B.C. Canada (“Developer”).
EXCHANGE AGREEMENTExchange Agreement • March 12th, 2018 • Pivot Pharmaceuticals Inc. • Pharmaceutical preparations • New York
THRUDERMIC LLC, a limited liability company incorporated pursuant to the laws of North Carolina and having an address at 4843 Gate Post Lane, Wilmington, NC 28412
The GLOBE LABORATORIES INC. NON-EXCLUSIVE LICENSE AGREEMENT Agreement June 17, 2008Non-Exclusive License Agreement • December 3rd, 2009 • Neurokine Pharmaceuticals Inc. • Pharmaceutical preparations • British Columbia
This License Agreement (“AGREEMENT”) is made as of the 17 day of June, 2008 (“EFFECTIVE DATE”), between Globe Laboratories Inc., a British Columbia corporation, having a principal place of business at 2386 East Mall, Suite 307, Vancouver, BC. V6T 1Z3 (“LICENSOR”) and Neurokine Pharmaceuticals Inc. (“LICENSEE), a British Columbia Corporation, having a business office at…1255 West Pender Street, Vancouver, B.C. V6E 2V1, each referred to herein individually as a “PARTY” and collectively as the “PARTIES”.
BINDING LETTER OF INTENT – TECHNOLOGY LICENSING AGREEMENTTechnology Licensing Agreement • December 15th, 2017 • Pivot Pharmaceuticals Inc. • Pharmaceutical preparations
FIELD Pivot wishes to acquire worldwide rights for the development and commercialization of Thrudermic Nano Technology for all cannabinoids.
DEBT SETTLEMENT AGREEMENTDebt Settlement Agreement • December 15th, 2017 • Pivot Pharmaceuticals Inc. • Pharmaceutical preparations • British Columbia
Pivot Pharmaceuticals Inc., a company incorporated under the laws of British Columbia and having its head office located at 1275 West 6th Avenue, Suite 300, Vancouver, BC Canada V6H 1A6
ContractRoyalty Agreement • March 12th, 2018 • Pivot Pharmaceuticals Inc. • Pharmaceutical preparations • California
THIS ROYALTY AGREEMENT (this “ Agreement ”) is entered into as of March 1, 2018 (the “ Effective Date ”), by and between Pivot Pharmaceuticals Inc., a corporation amalgamated under the Canada Business Corporations Act and having its head office at #300-1275 West 6th Avenue, Vancouver, British Columbia Canada, V6H 1A6 , (“ Company ” or “ Pivot ”), and AquaBrew Inc., a California corporation doing business as “Cafejo” (“ Cafejo ”). Pivot and Cafejo are sometimes referred to herein individually as a “ Party ” and collectively as “ Parties .”
EXCHANGE AGREEMENTExchange Agreement • March 12th, 2018 • Pivot Pharmaceuticals Inc. • Pharmaceutical preparations • British Columbia
ERS HOLDINGS, LLC, a limited liability company incorporated pursuant to the laws of California and having an address at 11138 Del Amo Blvd #129, Lakewood, CA 90715
EMPLOYMENT AGREEMENTEmployment Agreement • December 15th, 2015 • Pivot Pharmaceuticals Inc. • Pharmaceutical preparations • Massachusetts
THIS EMPLOYMENT AGREEMENT (the "Agreement") is effective the 20th day of November, 2015 (the "Effective Date"), by and between Pivot Pharmaceuticals, Inc., a British Columbia corporation (the "Company") and Pravin Chaturvedi (the "Executive").
PIVOT – ALTUM LICENSING AGREEMENT– Altum Licensing Agreement • September 13th, 2017 • Pivot Pharmaceuticals Inc. • Pharmaceutical preparations
This EXCLUSIVE LICENSING AGREEMENT is made this 12th day of September 2017 (hereinafter the “Effective Date”), by and between PIVOT PHARMACEUTICALS INC., a corporation organized under the laws of British Columbia with an address c/o Alexander Holburn Beaudin & Lang LLP at 2700-700 West Georgia Street, Vancouver, British Columbia V7Y 1B8 (hereinafter “PIVOT”) and ALTUM PHARMACEUTICALS INC., a corporation organized under the laws of British Columbia with an address c/o 1275 West 6th Street, Suite 300, Vancouver, BC V6C 1V5 (hereinafter “ALTUM”). PIVOT and ALTUM herein may be referred to individually as “Party” or together as “Parties.”
CONSULTING AGREEMENTConsulting Agreement • March 26th, 2015 • Neurokine Pharmaceuticals Inc. • Pharmaceutical preparations • British Columbia
NEUROKINE PHARMACEUTICALS INC., a British Columbia corporation having an address at 1275 West 6th Avenue, Vancouver, British Columbia V6H 1A6
EXCHANGE AGREEMENTSeparation Agreement • September 13th, 2017 • Pivot Pharmaceuticals Inc. • Pharmaceutical preparations • Delaware
THIS EXCHANGE AGREEMENT (this “Agreement”) is made as of September 11, 2017, by and among PIVOT PHARMACEUTICALS INC., a British Columbia Corporation (“PIVOT”), INDUS PHARMACEUTICALS, INC., a Delaware General Business Corporation (“INDUS” or the “COMPANY”) and PRAVIN CHATURVEDI (“CHATURVEDI”). Capitalized terms used and not otherwise defined herein have the meanings set forth in ARTICLE X.
Wakabayashi Fund, LLC Japanese Limited Liability Company, Address: 4-13-20 Mita Minato-Ku, Tokyo, Japan 108-0073 Hereinafter referred to as “WAKABAYASHI” or “Consultant” And NEUROKINE PHARMACEUTICALS, INC. A Vancouver, BC Corporation, its agents,...Agreement • August 29th, 2011 • Neurokine Pharmaceuticals Inc. • Pharmaceutical preparations • California
Whereas Consultant is in the business of providing management consulting services to businesses in an effort to obtain institutional capital from third parties for business use, including equipment leasing, purchase order and/ or contract financing, factoring and financing for land and buildings’ utilizing various financing instruments and whereas Client desires to retain Consultant for the following purposes:
THE GLOBE LABORATORIES INC. NON-EXCLUSIVE LICENSE AGREEMENT Agreement June 17, 2008Non-Exclusive License Agreement • August 7th, 2009 • Neurokine Pharmaceuticals Inc. • British Columbia
